Breaking News, Promotions & Moves

Radiant Biotherapeutics Names Deborah Geraghty President & CEO

New appointments to the leadership team also include Stefan Larson as Chair of the Board of Directors and Ingmar Bruns as a new Board Member.

By: Rachel Klemovitch

Assistant Editor

Radiant Biotherapeutics, a biotechnology company, made new leadership appointments. Biotechnology executive Deborah Geraghty, Ph.D., was named President and Chief Executive Officer, entrepreneur and venture investor Stefan Larson, Ph.D., was appointed Chair of the Board of Directors, and physician-scientist Ingmar Bruns, M.D., Ph.D., joined as a Board Member. These appointments follow the company’s $35 million Series A financing and build upon the recent progress by founding Chief Scien...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters